Molecular Profile | KRAS exon 4 |
Therapy | Cetuximab |
Indication/Tumor Type | colon cancer |
Response Type | resistant |
Create By | smockus |
Update By | tyin |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | KRAS exon 4 | colon cancer | resistant | Cetuximab | Guideline | Actionable | Erbitux (cetuximab) is not indicated for use in colon cancer patients with KRAS exon 4 mutation (NCCN.org). | detail... |
---|
PubMed Id | Reference Title | Details |
---|---|---|
NCCN.org | Full reference... |